临床研究

血液流变学指标与颈动脉粥样硬化的关系

  • 卢露星 ,
  • 谢静 ,
  • 向怡 ,
  • 郑玉华 ,
  • 巫廷春 ,
  • 吕大沩 ,
  • 许滔
展开
  • 1.贵州中医药大学第二临床医学院 (贵州 贵阳 550005 )
    2.贵州中医药大学第二附属医院心血管内科 (贵州 贵阳 550003 )

收稿日期: 2025-06-27

  网络出版日期: 2025-10-10

基金资助

国家自然科学基金资助项目(82460912)

The relationship between hemorheology and carotid atherosclerosis

  • Luxing LU ,
  • Jing XIE ,
  • Yi XIANG ,
  • Yuhua ZHENG ,
  • Tinchun WU ,
  • Dawei LV ,
  • Tao. XU
Expand
  • *.The Second Clinical Medical College,Guizhou University of Traditional Chinese Medicine,Guiyang 550005,Guizhou,China

Received date: 2025-06-27

  Online published: 2025-10-10

摘要

目的 探讨血液流变学指标与颈动脉粥样硬化(CAS)的相关性。 方法 回顾性收集完成颈动脉超声和血液流变学检查的患者共153例,根据是否患有CAS,分为CAS组96例和非CAS组57例。比较两组患者的一般临床资料和实验室指标,运用多因素logistic回归分析CAS发生的影响因素,同时绘制ROC曲线观察血液流变学指标预测CAS的作用,并根据最大约登指数选取最佳截断值。 结果 CAS组患者的年龄、体质量指数(BMI)、红细胞聚集指数、全血低切还原黏度、全血高切还原黏度、血浆黏度、纤维蛋白原水平均高于非CAS组(P < 0.05)。多因素logistic回归分析结果显示,血浆黏度(OR = 38.270,95%CI:1.206 ~ 1 214.508)、年龄(OR = 1.119,95%CI:1.065 ~ 1.176)是CAS发生的危险因素(P < 0.05)。ROC曲线显示血浆黏度、年龄的曲线下面积(AUC)分别为0.623、0.728。 结论 发生CAS的患者在血浆黏度、年龄等方面均较无CAS患者高,血浆黏度水平升高、老龄化是CAS发生的危险因素,血浆黏度≥ 1.46 mPa·s和年龄超过56.5岁对预测CAS有重要价值。

本文引用格式

卢露星 , 谢静 , 向怡 , 郑玉华 , 巫廷春 , 吕大沩 , 许滔 . 血液流变学指标与颈动脉粥样硬化的关系[J]. 实用医学杂志, 2025 , 41(19) : 3041 -3045 . DOI: 10.3969/j.issn.1006-5725.2025.19.012

Abstract

Objective To explore the relationship between hemorheology and Carotid Atherosclerosis. Methods The clinical data of 153 patients who underwent both hemorheological testing and carotid artery ultrasound were divided into a CAS group (n = 96) and a non?CAS group (n = 57) based on ultrasound findings. Clinical data and laboratory indicators were compared between two groups. Multivariate logistic regression analysis was used to explore the influencing factors of CAS. The ROC curves graph were drawn to observe the role of hemorheological indicators in predicting CAS and select the optimal cutoff value based on the maximum Youden index. Results The CAS group demonstrated higher levels in age, BMI, RBC aggregation index,low & high shear reduced viscosity of whole blood,plasma viscosity and fibrinogen compared to the non?CAS group (P < 0.05). The multivariate logistic regression analysis showed that plasma viscosity (OR = 38.270, 95% CI:1.206 ~ 1214.508),age (OR = 1.119, 95% CI: 1.065 ~ 1.176) were risk factors for the occurrence of CAS (P < 0.05). The ROC curves showed that the area under the curve (AUC) of plasma viscosity and age were 0.623、0.728. Conclusion CAS patients have high levels of plasma viscosity and advanged age compared to the patient without CAS. Elevated plasma viscosity and age is a risk factor for CAS, with plasma viscosity ≥ 1.46 mPa·s, over the age of 56.5 as a significant value for predicting CAS.

参考文献

[1] CHEN J, WANG B, SONG J,et al. Multiple techniques to evaluate the relationship between carotid artery plaque and acute stroke[J]. Clin Hemorheol Microcirc,2024,86(3):327-337. doi:10.3233/ch-231959
[2] SONG P, FANG Z, WANG H,et al. Global and regional prevalence,burden,and risk factors for carotid atherosclerosis: A systematic review,meta-analysis,and modelling study[J]. Lancet Glob Health,2020,8(5):e721-e729. doi:10.1016/s2214-109x(20)30117-0
[3] FLAHERTY M L, KISSELA B, KHOURY J C,et al. Carotid artery stenosis as a cause of stroke[J]. Neuroepidemiology,2013,40(1):36-41. doi:10.1159/000341410
[4] BENJAMIN E J, BLAHA M J, CHIUVE S E,et al. Heart Disease and Stroke Statistics-2017 Update:A Report From the American Heart Association[J]. Circulation,2017,135(10):e146-e603. doi:10.1161/cir.0000000000000530
[5] 陈运红,孙义波. 养血清脑颗粒联合瑞舒伐他汀对颈动脉粥样硬化合并高脂血症患者脂代谢及血液流变学的影响[J]. 临床合理用药,2025,18(7):45-47+52.
[6] 常国宁,郭严,康进忠,等. 丁苯酞联合脉血康胶囊对动脉粥样硬化性缺血性脑卒中患者神经功能及血液流变学的影响[J].河南医学研究,2024,33(12):2251-2255.
[7] 柴红杰. 阿加曲班联合硫酸氢氯吡格雷对动脉粥样硬化性脑梗死患者神经功能及血液流变学指标的影响[J]. 临床医学,2023,43(9):112-114.
[8] 华扬,蒋天安,温朝阳,等. 头颈部血管超声若干问题的专家共识(颈动脉部分)[J]. 中国脑血管病杂志,2020,17(6):346-353.
[9] 齐衍濛,李丹丹,陈安琪,等. 人体脂肪分布与颈动脉粥样硬化的相关性[J]. 协和医学杂志,2025,16(3):703-709.
[10] 牛稳,邱晓晖,刘艺超. 颈动脉粥样硬化狭窄的血管周围脂肪密度与脑梗死之间的关系[J]. 实用医学杂志,2023,39(1):103-108.
[11] 庞子磊,李春海,周清. 甘油三酯-葡萄糖指数与高血压人群颈动脉粥样硬化的相关性研究[J]. 中国循证心血管医学杂志,2025,17(5):611-615.
[12] 李燕,王广辉,董路晨,等. hsCRP、HCY与T2DM并颈动脉粥样硬化患者并发DMCI的相关性研究[J]. 湘南学院学报(医学版),2025,27(2):26-29.
[13] DAI G, CAI X, YE C,et al. A cross-sectional study of factors associated with carotid atherosclerosis[J]. Front Physiol,2024,15:1434173. doi:10.3389/fphys.2024.1434173
[14] CECEN S, CAGLAR S E, GULEKEN Z,et al. Fat mass is responsible for increased plasma and whole blood viscosity in obesity[J].Nutrition,2025,134:112714. doi:10.1016/j.nut.2025.112714
[15] ALEXY T, DETTERICH J, CONNES P,et al. Physical Properties of Blood and their Relationship to Clinical Conditions[J].Front Physiol,2022,13:906768. doi:10.3389/fphys.2022.906768
[16] MUSICK J O, FIBBEN K S, LAM W A. Hyperviscosity syndromes; hemorheology for physicians and the use of microfluidic devices[J]. Curr Opin Hematol,2022,29(6):290-296. doi:10.1097/moh.0000000000000735
[17] VALEAANU L, GINGHINA C, BUBENEK-TURCONI S. Blood Rheology Alterations in Patients with Cardiovascular Diseases[J].Rom J Anaesth Intensive Care,2022,28(2):41-46.
[18] CHEN W, HU B, ZHANG S,et al. Relationship between blood viscosity and existence and severity of carotid artery plaque[J].Clin Hemorheol Microcirc,2023,83(4):351-358. doi:10.3233/ch-221597
[19] CAIMI G, URSO C, BRUCCULERI S,et al. An assessment of the hemorheological profile in patients with subclinical carotid atherosclerosis divided in relation to the number of cardiovascular risk factors and different degrees of insulin resistance[J]. Clin Hemorheol Microcirc,2021,78(4):417-428. doi:10.3233/ch-211105
[20] TRIPOLINO C, IRACE C, CARALLO C,et al. Association between blood viscosity and common carotid artery elasticity[J].Clin Hemorheol Microcirc,2016,62(1):55-62. doi:10.3233/ch-151946
[21] TOTSIMON K, NAGY A, SANDOR B,et al. Hemorheological alterations in carotid artery stenosis[J]. Clin Hemorheol Microcirc,2016,64(1):55-63. doi:10.3233/ch-162043
[22] 张长军,陶庆春. 临床相关检验指标在血瘀证辨证分型中的应用[J]. 国际检验医学杂志,2015,36(12):1741-1743.
[23] 李晓瑞,翟雪琴,许红峰. 益气活血类方治疗冠状动脉粥样硬化性心脏病气虚血瘀证的研究新进展[J]. 中医临床研究, 2024,16(8):75-81.
[24] 李艳,赵洋,郑铁钢,等. 理气活血滴丸治疗气虚血瘀型冠心病心绞痛疗效及对血液流变学和炎症因子的影响[J]. 现代中西医结合杂志,2020,29(25):2820-2823.
[25] 孙天才,刘晓慧,平莉. 自拟益气活血通络方联合针刺治疗脑中风后遗症期气虚血瘀证的效果观察[J]. 实用中西医结合临床,2025,25(8):6-8+79.
[26] 王少朋,唐亚为,薛兵. 自拟益气活血汤加减治疗缺血性脑卒中(气虚血瘀证)的效果及对血清NGF、BDNF和血液流变学的影响[J]. 海南医学,2023,34(22):3214-3218.
[27] GE J J, XING Y Q, CHEN H X,et al. Analysis of young ischemic stroke patients in northeast China[J].Ann Transl Med,2020,8(1):3. doi:10.21037/atm.2019.12.72
[28] DONATO A J, MACHIN D R, LESNIEWSKI L A. Mechanisms of Dysfunction in the Aging Vasculature and Role in Age-Related Disease[J].Circ Res,2018,123(7):825-848. doi:10.1161/circresaha.118.312563
[29] VASILEVKO V, PASSOS GF, QRIRING D,et al. Aging and cerebrovascular dysfunction:Contribution of hypertension, cerebral amyloid angiopathy,and immunotherapy[J].Ann N Y Acad Sci,2010,1207:58-70. doi:10.1111/j.1749-6632.2010.05786.x
[30] 胡洁,陈庆伟,贺无恙,等. 增龄与动脉粥样硬化性心血管疾病临床类型的相关性分析[J]. 临床心血管病杂志,2018,34(11):1081- 1085.
[31] 黄美群,周德轩,梁雪冰. 不同年龄组血液流变学结果的变化与分析[J]. 中国血液流变学杂志,2006,16(2):279-281.
[32] 张丹凤,夏向南. 血液流变性变化与增龄的关系[J]. 微循环学杂志,2005,15(3):46-47.
[33] 宋玮,帅垠琦,王楷,等. 中药治疗颈动脉粥样硬化患者的临床特征、证型分布及用药规律研究[J]. 中成药,2025,47(6):2101-2108.
[34] FU J, DENG Y, MA Y,et al. National and Provincial-Level Prevalence and Risk Factors of Carotid Atherosclerosis in Chinese Adults[J]. JAMA Netw Open,2024,7(1):e2351225. doi:10.1001/jamanetworkopen.2023.51225
文章导航

/